LASIK for high myopic astigmatism resulting from perforating ocular injury.

To present a case of successful treatment of high myopic astigmatism after a perforating injury with significant corneal laceration and pupil ectopia using excimer LASIK.
A 30-year-old man presented for treatment of high myopic astigmatism in his right eye resulting from perforating ocular trauma, which occurred 8 years prior to presentation. The corneoscleral wound repair was performed with posterior chamber intraocular lens implantation. Uncorrected visual acuity (UCVA) in the right eye was counting fingers at 1 m, best corrected to 20/30 with -7.00 + 5.00 x 110. Visual acuity in the left eye was 20/20 with -1.5 D. The patient was unable to tolerate spectacles and contact lenses because of asthenopia and high astigmatism, respectively. As an alternative, LASIK with the Allegretto Wave excimer laser was performed.
Three months postoperatively, UCVA was 20/25 in the right eye and 20/15 in the left eye.
This case indicates that LASIK can be a useful surgical method for correcting high myopic astigmatism resulting from ocular trauma with significant corneoscleral laceration.
AuthorsJohnny M Khoury, Walid F Haddad, Baha' Noureddin
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) 2005 Nov-Dec Vol. 21 Issue 6 Pg. 756-9 ISSN: 1081-597X [Print] United States
PMID16329370 (Publication Type: Case Reports, Journal Article)
  • Adult
  • Astigmatism (etiology, pathology, surgery)
  • Cornea (innervation, pathology, surgery)
  • Corneal Topography
  • Eye Injuries, Penetrating (complications, pathology, surgery)
  • Follow-Up Studies
  • Humans
  • Keratomileusis, Laser In Situ
  • Male
  • Myopia (etiology, pathology, surgery)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: